We also analysed the hypermethylation frequencies of BMP3 and NDRG4—the two genes implemented in the Cologuard® (Exact Sciences Corporation, Madison, WI, USA) stool based CRC screening assay. This evidence concerns the gene NDRG4 and colorectal carcinoma.